Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 1/20 | 0.54 |
| ▸ | TGM2 | P21980 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | NPC1 | O15118 | 4/20 | 0.50 |
| ▸ | RAB9A | P51151 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | IDO1 | P14902 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3491749 | 0.89 | RAB9A (0.56) | TGM2ALDH1A1NPC1RAB9AMEN1 | |
| SCHEMBL15979119 | 0.84 | ALDH1A1 (0.44) | AKT1TGM2ALDH1A1NPC1RAB9A | |
| SCHEMBL28375941 | 0.83 | AKT1 (0.54) | AKT1TGM2ALDH1A1NPC1RAB9A | |
| SCHEMBL8840278 | 0.82 | RAB9A (0.57) | AKT1TGM2ALDH1A1NPC1RAB9A | |
| SCHEMBL7904447 | 0.82 | AKT1 (0.52) | AKT1TGM2ALDH1A1MEN1KMT2A | |
| SCHEMBL14837692 | 0.81 | TGM2 (0.50) | AKT1TGM2ALDH1A1NPC1RAB9A | |
| SCHEMBL21616630 | 0.81 | ALDH1A1 (0.53) | ALDH1A1NPC1RAB9AMEN1KMT2A | |
| SCHEMBL17997805 | 0.80 | LMNA (0.50) | ALDH1A1NPC1RAB9AMEN1KMT2A | |
| SCHEMBL7047441 | 0.80 | MAPT (0.52) | ALDH1A1NPC1RAB9ALMNAEPHX1 | |
| SCHEMBL76489 | 0.79 | ALDH1A1 (0.67) | ALDH1A1NPC1RAB9AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115108985-A | Synthesis method of 4- (cyclohexylmethyl) -2, 4-dimethylisoquinoline-1, 3(2H, 4H) -diketone | 浙江工业大学 | 2022-09-27 | — | — | CN | claimed |
| CN-113861240-A | Trifluoromethyl reagent and synthesis method and application thereof | 中国科学院大学 | 2021-12-31 | — | — | CN | claimed |
| US-5618829-A | SUPPRESSION GROWTH OF CANCER CELLS | MITSUBISHI CHEMICAL CORPORATION (JP) | 1997-04-08 | — | — | US | claimed |
| EP-0608897-A2 | Tyrosine kinase inhibitors and benzoylacrylamide derivatives | Mitsubishi Chemical Corporation (JP) | 1994-08-03 | — | — | EP | claimed |
| JP-6279272-A | — | — | None | — | — | JP | disclosed |
| US-20250332286-A1 | CHEMICALLY-MODIFIED ADENO-ASSOCIATED VIRUSES | CENTRE NAT RECH SCIENT (FR) | 2025-10-30 | — | — | US | disclosed |
| CN-119735523-A | Food flavoring compound N-phenylacrylamide acid and preparation method and application thereof | 华南理工大学 | 2025-04-01 | — | — | CN | disclosed |
| EP-4508222-A1 | CHEMICALLY-MODIFIED ADENO-ASSOCIATED VIRUSES | Centre National de la Recherche Scientifique (FR) | 2025-02-19 | — | — | EP | disclosed |
| CN-117098815-A | Rubberized asphalt composition having acrylic copolymer | 巴斯夫欧洲公司 | 2023-11-21 | — | — | CN | disclosed |
| WO-2023198652-A1 | CHEMICALLY-MODIFIED ADENO-ASSOCIATED VIRUSES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2023-10-19 | — | — | WO | disclosed |
| CN-114805127-B | Preparation method of 2-trifluoromethyl-1-tetralone compound | 武汉大学 | 2023-03-24 | — | — | CN | disclosed |
| CN-114805127-B | Preparation method of 2-trifluoromethyl-1-tetralone compound | 武汉大学 | 2023-03-24 | — | — | CN | disclosed |
| US-20020188084-A1 | Stimuli-responsive polymer utilizing keto-enol tautomerization and stimuli-responsive separating material and chemical-releasing capsule comprising the same | JNC CORPORATION (JP) | 2002-12-12 | — | — | US | disclosed |
| EP-0922715-A2 | Stimuli-responsive polymer utilizing keto-enol tautomerization | AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY MITI (JP) | 1999-06-16 | — | — | EP | disclosed |
| US-5618829-A | SUPPRESSION GROWTH OF CANCER CELLS | MITSUBISHI CHEMICAL CORPORATION (JP) | 1997-04-08 | — | — | US | disclosed |
| US-5618829-A | SUPPRESSION GROWTH OF CANCER CELLS | MITSUBISHI CHEMICAL CORPORATION (JP) | 1997-04-08 | — | — | US | disclosed |
| JP-H06279272-A | TYROSINE KINASE INHIBITOR | MITSUBISHI KASEI CORP | 1994-10-04 | — | — | JP | disclosed |
| EP-0608897-A2 | Tyrosine kinase inhibitors and benzoylacrylamide derivatives | Mitsubishi Chemical Corporation (JP) | 1994-08-03 | — | — | EP | disclosed |
| EP-0608897-A2 | Tyrosine kinase inhibitors and benzoylacrylamide derivatives | Mitsubishi Chemical Corporation (JP) | 1994-08-03 | — | — | EP | disclosed |
| EP-0608897-A2 | Tyrosine kinase inhibitors and benzoylacrylamide derivatives | Mitsubishi Chemical Corporation (JP) | 1994-08-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250332286-A1 | CHEMICALLY-MODIFIED ADENO-ASSOCIATED VIRUSES | AMDHD2, AADAC, ALDH1A2 | AKT1 4706/4885TGM2 2212/4885ALDH1A1 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.